bpc 157 huberman Insights BPC 157 | Ask Huberman

Is CJC-1295/Ipamorelin FDA Approved

The persistence of benefits after treatment cessation, observed in trials, suggests the possibility of periodic treatment cycles rather than continuous use

B12 has many functions in our body, so unfortunately a deficiency will give rise to a wide variety of symptoms, like brain fog, memory problems, cognitive impairment, insomnia, headaches, especially migraine, behavioural changes, learning problems, nominal aphasia, mood swings, irritability, depression, anxiety, hallucinations, delusions, psychosis, peripheral paraesthesia (pins and needles), numbness, neuropathic pains, poor balance, reduced vibration sense or proprioception (joint position sense), tinnitus, ataxia, taste impairment, sometimes myelopathy, fatigue, anaemia (either with larger red blood cells, or with normal size of the red blood cells when there is also iron deficiency), other reduction in blood cells, abdominal complaints, malabsorption, failure to thrive, weight loss, diarrhoea, hyperpigmentation, glossitis, (aphthous) stomatitis, infertility, urinary tract infections, joint and muscle pain, muscle weakness, spasticity, seizures, cardiomyopathy, urinary and/or faecal incontinence, postural hypotension/dizziness, erectile dysfunction, to name a few

Precision Localized Application: Allows for targeted external use on specific areas

By working with medical professionals, consultants and NHS eLearning for Health PAS has the first dedicated 12 module education programme live on the NHS Learning Hub